167 related articles for article (PubMed ID: 33884182)
1. Risk of neurodegenerative disease due to tau phosphorylation changes and arsenic exposure via drinking water.
Pakzad D; Akbari V; Sepand MR; Aliomrani M
Toxicol Res (Camb); 2021 Mar; 10(2):325-333. PubMed ID: 33884182
[TBL] [Abstract][Full Text] [Related]
2. Chronic Oral Arsenic Exposure and Its Correlation with Serum S100B Concentration.
Golmohammadi J; Jahanian-Najafabadi A; Aliomrani M
Biol Trace Elem Res; 2019 May; 189(1):172-179. PubMed ID: 30109550
[TBL] [Abstract][Full Text] [Related]
3. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):658-64. PubMed ID: 12410387
[TBL] [Abstract][Full Text] [Related]
4. The role of hippocampal tau protein phosphorylation in isoflurane-induced cognitive dysfunction in transgenic APP695 mice.
Li C; Liu S; Xing Y; Tao F
Anesth Analg; 2014 Aug; 119(2):413-419. PubMed ID: 24977637
[TBL] [Abstract][Full Text] [Related]
5. Ginkgo biloba extract (Egb761) attenuates zinc-induced tau phosphorylation at Ser262 by regulating GSK3β activity in rat primary cortical neurons.
Kwon KJ; Lee EJ; Cho KS; Cho DH; Shin CY; Han SH
Food Funct; 2015 Jun; 6(6):2058-67. PubMed ID: 26032477
[TBL] [Abstract][Full Text] [Related]
6. Arsenic-induced dyslipidemia in male albino rats: comparison between trivalent and pentavalent inorganic arsenic in drinking water.
Afolabi OK; Wusu AD; Ogunrinola OO; Abam EO; Babayemi DO; Dosumu OA; Onunkwor OB; Balogun EA; Odukoya OO; Ademuyiwa O
BMC Pharmacol Toxicol; 2015 Jun; 16():15. PubMed ID: 26044777
[TBL] [Abstract][Full Text] [Related]
7. Effects of lead exposure on the expression of amyloid β and phosphorylated tau proteins in the C57BL/6 mouse hippocampus at different life stages.
Liu F; Xue Z; Li N; Huang H; Ying Y; Li J; Wang L; Li W
J Trace Elem Med Biol; 2014 Apr; 28(2):227-232. PubMed ID: 24582137
[TBL] [Abstract][Full Text] [Related]
8. Arsenic intake via water and food by a population living in an arsenic-affected area of Bangladesh.
Ohno K; Yanase T; Matsuo Y; Kimura T; Rahman MH; Magara Y; Matsui Y
Sci Total Environ; 2007 Aug; 381(1-3):68-76. PubMed ID: 17481698
[TBL] [Abstract][Full Text] [Related]
9. Tau phosphorylation at Alzheimer's disease-related Ser356 contributes to tau stabilization when PAR-1/MARK activity is elevated.
Ando K; Oka M; Ohtake Y; Hayashishita M; Shimizu S; Hisanaga S; Iijima KM
Biochem Biophys Res Commun; 2016 Sep; 478(2):929-34. PubMed ID: 27520376
[TBL] [Abstract][Full Text] [Related]
10. Effect of cortistatin on tau phosphorylation at Ser262 site.
Rubio A; Pérez M; de Lecea L; Avila J
J Neurosci Res; 2008 Aug; 86(11):2462-75. PubMed ID: 18438934
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity.
Ando K; Maruko-Otake A; Ohtake Y; Hayashishita M; Sekiya M; Iijima KM
PLoS Genet; 2016 Mar; 12(3):e1005917. PubMed ID: 27023670
[TBL] [Abstract][Full Text] [Related]
12. Exposure to Environmental Arsenic and Emerging Risk of Alzheimer's Disease: Perspective Mechanisms, Management Strategy, and Future Directions.
Rahman MA; Hannan MA; Uddin MJ; Rahman MS; Rashid MM; Kim B
Toxics; 2021 Aug; 9(8):. PubMed ID: 34437506
[TBL] [Abstract][Full Text] [Related]
13. Prolonged arsenic exposure increases tau phosphorylation in differentiated SH-SY5Y cells: The contribution of GSK3 and ERK1/2.
Wisessaowapak C; Visitnonthachai D; Watcharasit P; Satayavivad J
Environ Toxicol Pharmacol; 2021 May; 84():103626. PubMed ID: 33621689
[TBL] [Abstract][Full Text] [Related]
14. Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262.
Saito T; Oba T; Shimizu S; Asada A; Iijima KM; Ando K
Hum Mol Genet; 2019 Sep; 28(18):3062-3071. PubMed ID: 31174206
[TBL] [Abstract][Full Text] [Related]
15. Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease.
Iijima K; Gatt A; Iijima-Ando K
Hum Mol Genet; 2010 Aug; 19(15):2947-57. PubMed ID: 20466736
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity patterns of arsenic trioxide exposure on HaCaT keratinocytes.
Udensi UK; Graham-Evans BE; Rogers C; Isokpehi RD
Clin Cosmet Investig Dermatol; 2011; 4():183-90. PubMed ID: 22253543
[TBL] [Abstract][Full Text] [Related]
17. Arsenic Exposure Contributes to the Bioenergetic Damage in an Alzheimer's Disease Model.
Niño SA; Morales-Martínez A; Chi-Ahumada E; Carrizales L; Salgado-Delgado R; Pérez-Severiano F; Díaz-Cintra S; Jiménez-Capdeville ME; Zarazúa S
ACS Chem Neurosci; 2019 Jan; 10(1):323-336. PubMed ID: 30141907
[TBL] [Abstract][Full Text] [Related]
18. Tau passive immunization inhibits not only tau but also Aβ pathology.
Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of 3,3'-Dimethylbenzidine Dihydrochloride (CAS No. 612-82-8) in F344/N Rats (Drinking Water Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1991 Jun; 390():1-238. PubMed ID: 12637969
[TBL] [Abstract][Full Text] [Related]
20. Subchronic exposure to arsenic through drinking water alters expression of cancer-related genes in rat liver.
Cui X; Li S; Shraim A; Kobayashi Y; Hayakawa T; Kanno S; Yamamoto M; Hirano S
Toxicol Pathol; 2004; 32(1):64-72. PubMed ID: 14713550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
